The director of Oregon Health & Science University’s $1 billion Knight Cancer Institute resigned this week after just one year on the job, leaving OHSU with yet another interim leader in a key role.
Dr. Tom Sellers joined the cancer institute in February 2023 as lead research officer. He became director in March 2024, when Dr. Brian Druker took a newly created position as chief executive officer, where he could focus on long-term vision, strategic planning and fundraising, OHSU said at the time.
In an email to staff, Sellers gave no reason for his departure, beyond alluding to tough conditions in medical research and at OHSU…